Novel heteroleptic ruthenium complexes incorporating 6,7-dichloro-2,3-di(pyridine-2-yl)quinoxaline as polypyridyl bridging ligand: Synthesis, characterization, photophysical, electrochemistry, in vitro biological activity and molecular docking studies DOI

Mohamed M. Hammam,

Ramadan M. Ramadan, Ayman A. Abdel Aziz

и другие.

Journal of Molecular Structure, Год журнала: 2024, Номер 1323, С. 140748 - 140748

Опубликована: Ноя. 16, 2024

Язык: Английский

Identification, crystallization, and first X-ray structure analyses of phenyl boronic acid-based inhibitors of human carbonic anhydrase-II DOI
Saima Rasheed, Noor ul Huda, S. Zoë Fisher

и другие.

International Journal of Biological Macromolecules, Год журнала: 2024, Номер 267, С. 131268 - 131268

Опубликована: Апрель 4, 2024

Язык: Английский

Процитировано

4

Phytochemical analysis, antioxidant, anticancer, and antibacterial potential of Alpinia galanga (L.) rhizome DOI Creative Commons
Ibrahim M. Aziz,

Akram A. Alfuraydi,

Omer M. Almarfadi

и другие.

Heliyon, Год журнала: 2024, Номер 10(17), С. e37196 - e37196

Опубликована: Авг. 31, 2024

Язык: Английский

Процитировано

4

Drug repurposing: Identification and X-ray crystallographic analyses of US-FDA approved drugs against carbonic anhydrase-II DOI
Saima Rasheed,

Noo Rul Huda,

Zoha Warsi

и другие.

International Journal of Biological Macromolecules, Год журнала: 2025, Номер unknown, С. 141057 - 141057

Опубликована: Фев. 1, 2025

Язык: Английский

Процитировано

0

Sulfonamide‐Bearing Pyrazolone Derivatives as Multitarget Therapeutic Agents: Design, Synthesis, Characterization, Biological Evaluation, In Silico ADME/T Profiling and Molecular Docking Study DOI Creative Commons
Nebih Lolak, Süleyman Akocak, Meryem Topal

и другие.

Pharmacology Research & Perspectives, Год журнала: 2025, Номер 13(2)

Опубликована: Март 24, 2025

The research and design of new inhibitors for the treatment diseases such as Alzheimer's disease glaucoma through inhibition cholinesterases (ChEs; acetylcholinesterase, AChE butyrylcholinesterase, BChE) carbonic anhydrase enzymes are among important targets. Here, a series novel sulfonamide-bearing pyrazolone derivatives (1a-f 2a-f) were successfully synthesized characterized by using spectroscopic analytical methods. inhibitory activities these newly compounds evaluated both in vitro silico their effect on anhydrases (hCA I hCA II isoenzymes) ChEs. studies showed that demonstrated potential activity, with KI values covering following ranges: 18.03 ± 2.86-75.54 4.91 nM I, 24.84 1.57-85.42 6.60 II, 7.45 0.98-16.04 1.60 AChE, 34.78 5.88-135.70 17.39 BChE. Additionally, many promising some higher potency than reference compounds. While have also identified binding positions compounds, crystal structures BChE receptors. varying affinities designed ChEs isoenzymes show could hold promise alternative agents selectively inhibiting hCAs glaucoma.

Язык: Английский

Процитировано

0

Isoindole‐1,3‐Dione Sulfonamides as Potent Inhibitors of Glucosidase, Aldose Reductase, and Tyrosinase: A Molecular Docking and Enzyme Inhibition Study DOI
Zafer Aslan, Esra Yılmaz,

Nurgül Pulat

и другие.

Biotechnology and Applied Biochemistry, Год журнала: 2025, Номер unknown

Опубликована: Апрель 1, 2025

Diabetes mellitus, especially type 2, is a global health challenge, and effective enzyme inhibitors are essential for its control. Conventional have drawbacks such as gastrointestinal side effects regional availability, examples being acarbose epalrestat. Moreover, tyrosinase, which controls melanin synthesis also target reducing hyperpigmentation disorders. In this study, we demonstrate the inhibitory action of novel isoindole-1,3-dione-based sulfonamides against key enzymes associated with diabetes hyperpigmentation, α-Glucosidase (α-Glu), aldose reductase (ALR2), tyrosinase. The presynthesized compounds (3, 4a-k) tested in vitro inhibition α-Glu, ALR2, tyrosinase compared reference acarbose, epalrestat, kojic acid. Kinetic studies showed that both competitive noncompetitive modes were observed. Among them, compound 4a displayed highest ALR2 potency (Ki: 0.211 µM) was superior to terms 4k shown be more potent Ki 0.049 µM, particularly versus acarbose. Compound 4d excellent activity 1.43 assays, much than Molecular docking revealed details enzyme-binding interactions, justify respective mechanisms Structure-activity relationships reflected strong hydrogen bonding hydrophobic interactions led higher potency. These findings highlight importance therapeutic agents will provide valuable leads developing multifunctional diabetic complications hyperpigmentation.

Язык: Английский

Процитировано

0

Design, Synthesis, Characterization and Exploration of Biological Efficacy of Iminothiazoline Sulfonamide Hybrids as Efficient Inhibitor of Carbonic Anhydrase DOI

Mian Bilal Haider,

Rajnee Kanwal,

Atteeque Ahmed

и другие.

Journal of Molecular Structure, Год журнала: 2025, Номер unknown, С. 142331 - 142331

Опубликована: Апрель 1, 2025

Язык: Английский

Процитировано

0

Comprehensive Insights into Carbonic Anhydrase Inhibition: A Triad of In vitro, In silico, and In vivo Perspectives DOI
Ahmed A. Allam, Hassan A. Rudayni, Noha Ahmed

и другие.

Enzyme and Microbial Technology, Год журнала: 2025, Номер 189, С. 110657 - 110657

Опубликована: Апрель 17, 2025

Язык: Английский

Процитировано

0

Naphthoquinones and anthraquinones: Exploring their impact on acetylcholinesterase enzyme activity DOI Creative Commons
Hatice Esra Duran, Şükrü Beydemir

Biotechnology and Applied Biochemistry, Год журнала: 2024, Номер 71(5), С. 1079 - 1093

Опубликована: Май 7, 2024

The identification of novel acetylcholinesterase inhibitors holds significant relevance in the treatment Alzheimer's disease (AD), prevailing form dementia. exploration alternative to conventional is steadily gaining prominence. Quinones, categorized as plant metabolites, represent a specific class compounds. In this study, inhibitory effects various naphthoquinone derivatives, along with anthraquinone and its on (AChE) enzyme were investigated for purpose. An vitro investigation was conducted examine these compounds order clarify possible mechanism inhibition interaction between chemicals. addition, an silico carried out understand conceivable inhibitor binding process enzyme's active site. acquired outcomes corroborated results. AChE found be effectively inhibited by both naphthoquinones anthraquinones, constant (K

Язык: Английский

Процитировано

2

The effects of morin and methotrexate on pentose phosphate pathway enzymes and GR/GST/TrxR enzyme activities: An in vivo and in silico study DOI
Cüneyt Çağlayan, Yusuf Temel, Cüneyt Türkeş

и другие.

Archiv der Pharmazie, Год журнала: 2023, Номер 357(2)

Опубликована: Ноя. 16, 2023

Abstract In this study, the mechanisms by which enzymes glucose‐6‐phosphate dehydrogenase (G6PD), 6‐phosphogluconate (6PGD), glutathione reductase (GR), glutathione‐S‐transferase (GST), and thioredoxin (TrxR) are inhibited methotrexate (MTX) were investigated, as well whether antioxidant morin can mitigate or prevent these adverse effects in vivo silico. For 10 days, rats received oral doses of (50 100 mg/kg body weight). On fifth day, a single intraperitoneal injection MTX (20 weight) was administered to generate toxicity. Decreased activities G6PD, 6PGD, GR, GST, TrxR associated with MTX‐related toxicity while treatment increased activity enzymes. The docking analysis indicated that H‐bonds, pi–pi stacking, pi–cation interactions dominant enzyme‐binding pockets. Furthermore, docked poses against GST subjected molecular dynamic simulations for 200 ns, assess stability both complexes also predict key amino acid residues binding pockets throughout simulation. results study suggest may be viable means alleviating enzyme important regulatory MTX‐induced

Язык: Английский

Процитировано

5

Some pyrroles as inhibitors of the pentose phosphate pathways enzymes: An in vitro and molecular docking study DOI
Muhammet Serhat Özaslan

Journal of Molecular Recognition, Год журнала: 2024, Номер 37(3)

Опубликована: Март 21, 2024

Abstract Glucose‐6‐phosphate dehydrogenase (G6PD) and 6‐phosphogluconate (6PGD) are pentose phosphate pathway enzymes. Compounds with a heterocyclic pyrrole ring system containing this atom can be derivatized various functional groups into highly effective bioactive agents. In study, derivatives on these enzyme's activity were investigated. The IC 50 values of different concentrations for G6PD found in the range 0.022–0.221 mM K i 0.021 ± 0.003–0.177 6PGD 0.020–0.147, 0.013 0.002–0.113 0.030 mM. 2‐acetyl‐1‐methylpyrrole ( 1g ) showed best inhibition value addition, silico molecular docking experiments performed to elucidate how 1a – g interact binding sites target study's findings could used create innovative therapeutics that treatment many diseases, especially cancer manifestations.

Язык: Английский

Процитировано

1